192 related articles for article (PubMed ID: 16201830)
1. Determination of the conformation of trimethoprim in the binding pocket of bovine dihydrofolate reductase from a STD-NMR intensity-restrained CORCEMA-ST optimization.
Jayalakshmi V; Krishna NR
J Am Chem Soc; 2005 Oct; 127(40):14080-4. PubMed ID: 16201830
[TBL] [Abstract][Full Text] [Related]
2. Refinement of the conformation of UDP-galactose bound to galactosyltransferase using the STD NMR intensity-restrained CORCEMA optimization.
Jayalakshmi V; Biet T; Peters T; Krishna NR
J Am Chem Soc; 2004 Jul; 126(28):8610-1. PubMed ID: 15250687
[TBL] [Abstract][Full Text] [Related]
3. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
4. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities.
Jayalakshmi V; Rama Krishna N
J Magn Reson; 2004 May; 168(1):36-45. PubMed ID: 15082247
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the binding of a carbohydrate-mimetic peptide to its complementary anticarbohydrate antibody by STD-NMR spectroscopy and molecular-dynamics simulations.
Szczepina MG; Bleile DW; Pinto BM
Chemistry; 2011 Oct; 17(41):11446-55. PubMed ID: 21953925
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
[TBL] [Abstract][Full Text] [Related]
7. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
8. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
[TBL] [Abstract][Full Text] [Related]
9. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
[TBL] [Abstract][Full Text] [Related]
10. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
Jayalakshmi V; Krishna NR
J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
[TBL] [Abstract][Full Text] [Related]
11. Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative.
Popov VM; Chan DC; Fillingham YA; Atom Yee W; Wright DL; Anderson AC
Bioorg Med Chem Lett; 2006 Aug; 16(16):4366-70. PubMed ID: 16750361
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
[TBL] [Abstract][Full Text] [Related]
13. NMR-derived folate-bound structure of dihydrofolate reductase 1 from the halophile Haloferax volcanii.
Boroujerdi AF; Young JK
Biopolymers; 2009 Feb; 91(2):140-4. PubMed ID: 18825778
[TBL] [Abstract][Full Text] [Related]
14. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
[TBL] [Abstract][Full Text] [Related]
15. Basis of selectivity of antibacterial diaminopyrimidines.
Baccanari DP; Kuyper LF
J Chemother; 1993 Dec; 5(6):393-9. PubMed ID: 8195830
[TBL] [Abstract][Full Text] [Related]
16. Influence of environment on the antifolate drug trimethoprim: energy minimization studies.
Fisher CL; Roberts VA; Hagler AT
Biochemistry; 1991 Apr; 30(14):3518-26. PubMed ID: 2012811
[TBL] [Abstract][Full Text] [Related]
17. The conformations of trimethoprim/E. coli dihydrofolate reductase complexes. A 15N and 31P NMR study.
Huang FY; Yang QX; Huang TH; Gelbaum L; Kuyper LF
FEBS Lett; 1991 May; 283(1):44-6. PubMed ID: 2037072
[TBL] [Abstract][Full Text] [Related]
18. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
19. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of trimethoprim bound to dihydrofolate reductase--a deuterium NMR study.
Yang QX; Huang FY; Lin TH; Gelbaum L; Howell EE; Huang TH
Solid State Nucl Magn Reson; 1996 Dec; 7(3):193-201. PubMed ID: 9050157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
